Cwm, LLC Statera Biopharma, Inc. Transaction History

Cwm, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$0.08 - $0.23 $344 - $989	-4,300 Reduced 96.63%	150 $0
Q2 2022 Jul 28, 2022	BUY	$0.21 - $0.38 $934 - $1,691	4,450 New	4,450 $1,000
Q1 2022 Apr 21, 2022	SELL	$0.31 - $2.27 $139 - $1,021	-450 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$2.01 - $4.08 $904 - $1,836	450 New	450 $1,000

30K

Ticker STAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,295,700
Description
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.